Skip to main content
. 2022 Mar 28;11(7):1142. doi: 10.3390/cells11071142

Table 1.

Reviews from the past 5 years highlighting the potential impact of cannabis intake on the increase in risk of myocardial infarction and other severe cardiovascular disorders.

Type of study
Number of Patients/
Sample/Evaluation Period
Results Final Conclusion References
Systematic review
115 articles (81 case reports, 29 observational studies, 3 clinical trials and 2 experimental studies). 116 individuals in case reports, mean age 31 (2011–2016)
  • -

    individuals (82% men) mainly suffered from ischemic strokes (27 cases) or myocardial infarctions (33 cases)

  • -

    11 deaths from cardiovascular disease following exposure to cannabis-based products

association between exposure to cannabis-based products and cardiovascular disease; evidence stronger for ischemic strokes than for any other cardiovascular diseases [54]
Epidemiologic study from NIS
2,451,933 acute MI patients, mean age 49 (2010-2014)
cannabis use raised the risk of acute MI by 3–8% importance of patient history including recreational drug use in identifying the etiology of an unexplained MI [55]
Epidemiologic study from NIS
316,397 patients, aged 18–55 (2009–2010)
heart failure (1.4 vs. 1.2%), cerebrovascular accidents (1.03 vs. 0.62%), CAD (5.0 vs. 4.6%) and sudden cardiac death (0.21 vs. 0.17%) significantly higher in cannabis users cannabis use is an independent predictor of heart failure and cerebrovascular accidents [56]
Retrospective cohort analysis
292,770 patients with a history of cannabis abuse and 10,542,348 age- and sex-matched controls, mean age 37 (2011–2016)
3-year cumulative incidence of MI significantly higher in the cannabis-abuse group than in controls (1.37% vs. 0.54%);
most pronounced risk in the young and middle-aged
cannabis abuse may be associated with an elevated risk of MI independent of other cardiovascular risk factors, with higher relative risk in women and younger age groups [53]
Epidemiologic study from NIS
52,290,927 hospitalized patients,
aged 18–39 years (2007–2014)
hospitalizations among young cannabis users, compared to non-users increased by 50% for MI, 79% for arrhythmias, 300% for stroke and 75% for venous thromboembolic events young cannabis users are more at risk in hospitalizations for acute MI, arrhythmia, and stroke [57]
Scoping review
92 articles (1 randomized control trial, 4 systematic reviews, 19 literature reviews, 11 large database reviews, and 42 case reports/series) (2003–2018)
  • -

    51 cases of cannabis-related MI

  • -

    71% of patients suffered from ST elevation MI (STEMI)

  • -

    22% of patients presented with an out-of-hospital cardiac arrest or had an arrest prior to intervention; half of these patients died

  • -

    cannabis-induced MI especially prevalent among young healthy patients, presenting shortly after use

  • -

    users aged 18–36 years had an increased risk for acute coronary syndrome compared to non-users

[13]
Epidemiologic study from NHANES
89.6 million adults who reported
marijuana use (2005–2016)
2015–2016: 2 million (2.3%) cannabis users have a cardiovascular disease screening for marijuana use should be conducted in young patients with cardiovascular disease [14]
Epidemiologic study from NIS
3,307,310 hospitalizations
were noted with cannabis use disorder,
mean age 36 (2007–2014)
among cannabis users 0.7% (n = 24,148) had malignant
hypertension
it is necessary to develop an intervention to raise awareness regarding the deleterious effect of cannabis use and to curtail additional healthcare costs [58]
Retrospective longitudinal cohort study
18,653 adult cannabis patients were matched to 51,243 controls,
aged 31–60 years (2014–2017)
incidence rates for ACS or stroke were 7.19/1000 and 5.67/1000 person/year in the cannabis and control group medical cannabis authorization associated with increased risk of ED visits or hospitalization for cardiovascular events including stroke and ACS [59]
Systematic review
16 studies: 4 cohort, 8 case-control studies,
1 case-crossover study, 2 randomized controlled trials and 1 descriptive study with 10 to 118,659,619 participants (1970–2018)
marijuana use was related to an increased risk
of MI in 2 studies and
of stroke in 6 studies
(within 24 h)
marijuana users may be at increased risk of cardiovascular events [60]
Epidemiologic study from NHANES
3634 participants (1988–1994)
about 26.0% (n = 900) of participants (mean age 48) were ever cannabis users and 15.5%
(n = 538) had myocardial injury
cannabis use increased risk of myocardial injury among people without cardiovascular disease; effect increased by coexistent hypertension [61]
Epidemiologic study from BRFSS
33,173 young adult par-ticipants, 4610 (17.5%) respondents reported
recent cannabis use (2017–2018)
MI more frequent among recent cannabis users (61 of 4610, 1.3%) relative to non-users (240 of 28,563, 0.8%)
history of MI associated with cannabis use of more than 4 times per month and with smoking as the primary method of consumption
  • -

    association between recent cannabis use and history of MI in young adults

  • -

    increasing cannabis use in an at-risk population might have negative implications for cardiovascular health

[62]

ACS, acute coronary syndrome; BRFSS Behavioral Risk Factor Surveillance System Survey; CAD, coronary artery disease; ED, emergency department; MI, myocardial infarction; NHANES, National Health and Nutrition Examination Survey; NIS, National Inpatient Sample; STEMI, ST segment elevation myocardial infarction.